Literature DB >> 25839235

Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.

Tejas S Tirodkar1, Ping Lu1, Aiping Bai2, Matthew J Scheffel1, Salih Gencer3, Elizabeth Garrett-Mayer4, Alicja Bielawska2, Besim Ogretmen2, Christina Voelkel-Johnson5.   

Abstract

A family of six ceramide synthases with distinct but overlapping substrate specificities is responsible for generation of ceramides with acyl chains ranging from ∼14-26 carbons. Ceramide synthase 6 (CerS6) preferentially generates C14- and C16-ceramides, and we have previously shown that down-regulation of this enzyme decreases apoptotic susceptibility. In this study, we further evaluated how increased CerS6 expression impacts sphingolipid composition and metabolism. Overexpression of CerS6 in HT29 colon cancer cells resulted in increased apoptotic susceptibility and preferential generation of C16-ceramide, which occurred at the expense of very long chain, saturated ceramides. These changes were also reflected in sphingomyelin composition. HT-CerS6 cells had increased intracellular levels of sphingosine, which is generated by ceramidases upon hydrolysis of ceramide. qRT-PCR analysis revealed that only expression of acid ceramidase (ASAH1) was increased. The increase in acid ceramidase was confirmed by expression and activity analyses. Pharmacological inhibition of JNK (SP600125) or curcumin reduced transcriptional up-regulation of acid ceramidase. Using an acid ceramidase promoter driven luciferase reporter plasmid, we demonstrated that CerS1 has no effect on transcriptional activation of acid ceramidase and that CerS2 slightly but significantly decreased the luciferase signal. Similar to CerS6, overexpression of CerS3-5 resulted in an ∼2-fold increase in luciferase reporter gene activity. Exogenous ceramide failed to induce reporter activity, while a CerS inhibitor and a catalytically inactive mutant of CerS6 failed to reduce it. Taken together, these results suggest that increased expression of CerS6 can mediate transcriptional activation of acid ceramidase in a JNK-dependent manner that is independent of CerS6 activity.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  acid ceramidase; c-Jun transcription factor; cell death; ceramide synthase; colon cancer; sphingolipid

Mesh:

Substances:

Year:  2015        PMID: 25839235      PMCID: PMC4505570          DOI: 10.1074/jbc.M114.631325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.

Authors:  Jinyong Luo; Zhong-Liang Deng; Xiaoji Luo; Ni Tang; Wen-Xin Song; Jin Chen; Katie A Sharff; Hue H Luu; Rex C Haydon; Kenneth W Kinzler; Bert Vogelstein; Tong-Chuan He
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 2.  Intracellular signal transduction pathways activated by ceramide and its metabolites.

Authors:  Peter P Ruvolo
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

Review 3.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Authors:  M Verheij; R Bose; X H Lin; B Yao; W D Jarvis; S Grant; M J Birrer; E Szabo; L I Zon; J M Kyriakis; A Haimovitz-Friedman; Z Fuks; R N Kolesnick
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

5.  A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy.

Authors:  Yael Pewzner-Jung; Ori Brenner; Svantje Braun; Elad L Laviad; Shifra Ben-Dor; Ester Feldmesser; Shirley Horn-Saban; Daniela Amann-Zalcenstein; Calanit Raanan; Tamara Berkutzki; Racheli Erez-Roman; Oshrit Ben-David; Michal Levy; Dorin Holzman; Hyejung Park; Abraham Nyska; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

6.  Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.

Authors:  Nicole Sänger; Eugen Ruckhäberle; Balazs Györffy; Knut Engels; Tomas Heinrich; Tanja Fehm; Anna Graf; Uwe Holtrich; Sven Becker; Thomas Karn
Journal:  Mol Oncol       Date:  2014-07-31       Impact factor: 6.603

7.  Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.

Authors:  Daniela Hartmann; Jessica Lucks; Sina Fuchs; Susanne Schiffmann; Yannick Schreiber; Nerea Ferreirós; Jennifer Merkens; Rolf Marschalek; Gerd Geisslinger; Sabine Grösch
Journal:  Int J Biochem Cell Biol       Date:  2012-01-02       Impact factor: 5.085

8.  Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis.

Authors:  Susanne Schiffmann; Nerea Ferreiros; Kerstin Birod; Max Eberle; Yannick Schreiber; Waltraud Pfeilschifter; Ulf Ziemann; Sandra Pierre; Klaus Scholich; Sabine Grösch; Gerd Geisslinger
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

Review 9.  Sphingolipids in apoptosis.

Authors:  T S Tirodkar; C Voelkel-Johnson
Journal:  Exp Oncol       Date:  2012-10

10.  Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer.

Authors:  Lars Christian Hanker; Thomas Karn; Uwe Holtrich; Regine Gätje; Achim Rody; Tomas Heinrich; Eugen Ruckhäberle; Knut Engels
Journal:  Int J Gynecol Pathol       Date:  2013-05       Impact factor: 2.762

View more
  18 in total

1.  Analysis of the uterine lumen in fertility-classified heifers: I. Glucose, prostaglandins, and lipids†.

Authors:  Joao G N Moraes; Susanta K Behura; Thomas W Geary; Thomas E Spencer
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

2.  Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Authors:  Ping Lu; Shai White-Gilbertson; Rose Nganga; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2019-03-05       Impact factor: 4.742

3.  Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.

Authors:  Nicholas U Schwartz; Ryan W Linzer; Jean-Philip Truman; Mikhail Gurevich; Yusuf A Hannun; Can E Senkal; Lina M Obeid
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 4.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

Review 5.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

6.  Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.

Authors:  Shai White-Gilbertson; Ping Lu; James S Norris; Christina Voelkel-Johnson
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

Review 7.  Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.

Authors:  E Ramsay Camp; Logan D Patterson; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2017-07-07       Impact factor: 4.742

Review 8.  Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target.

Authors:  Mengmeng Lin; Yingying Li; Shiyuan Wang; Bo Cao; Chunyu Li; Guohui Li
Journal:  J Oncol       Date:  2022-06-28       Impact factor: 4.501

9.  Ceramide synthesis regulates T cell activity and GVHD development.

Authors:  M Hanief Sofi; Jessica Heinrichs; Mohammed Dany; Hung Nguyen; Min Dai; David Bastian; Steven Schutt; Yongxia Wu; Anusara Daenthanasanmak; Salih Gencer; Aleksandra Zivkovic; Zdzislaw Szulc; Holger Stark; Chen Liu; Ying-Jun Chang; Besim Ogretmen; Xue-Zhong Yu
Journal:  JCI Insight       Date:  2017-05-18

10.  Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.

Authors:  Baharan Fekry; Amin Esmaeilniakooshkghazi; Sergey A Krupenko; Natalia I Krupenko
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.